Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Buy the Dip In Square Stock

Shares of digital payments company Square have dipped 3% after the company reported humdrum quarterly results, presenting investors with a great buying opportunity. Following the latest dip, Square's stock is up a modest 4% over the past six months and has underperformed the S&P 500 index, which is up 13% during the same period.

RWLK Stock Alert: The FDA News That Has ReWalk Robotics Surging 30%

RWLK stock is up 30% after ReWalk Robotics cleared an important hurdle with the FDA, putting its ReBoot on track for commercialization.

Peloton Stock Price Plunges 30% as PTON Watches ‘Home Fitness’ Dry Up

Peloton stock is in freefall after the company reported a terrible quarter and gave weak forward guidance in its latest financial results.

3 Restaurant Stocks to Buy as Portillo’s IPO Puts Food in Focus

Hot dog restaurant chain Portillo’s held a successful IPO in mid-October that raised $400 million, and that has put food in focus for many investors. Here are three restaurant stocks that can put some heft into investor portfolios.

EVAX Stock: 10 Things to Know as Little-Known Evaxion Rockets 100% Today

With its stock price up nearly 200% in today's premarket, it's time for investors to get to known Danish company Evaxion Biotech.